TG Therapeutics stock price
TG 테라퓨틱스NASDAQ:TGTX · Nasdaq · HealthcareToday's signals · Death cross, VCP
Signal details →TG Therapeutics last closed at $54.29 (+1.25%) on 2026-10-02. Signals today: Death cross, VCP. Listed on Nasdaq. Trailing 12 months PER is 19.3×. Its overall grade ranks 280 of 739 stocks in Healthcare.
About this company
TG Therapeutics last closed at $54.29 (+1.25%) on 2026-10-02. Signals today: Death cross, VCP. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 280/739
Valuation grade F
Related stocks
- RocheCompetitor
B세포질환·다발성경화증 등에서 TG Therapeutics와 치료제 경쟁
- NovartisCompetitor
MS 치료제 시장의 글로벌 경쟁사
- BiogenCompetitor
재발성 다발성경화증 등에서 직접 경쟁
ETFs holding this stock
Innovator IBD Breakout Opportunities ETF · Invesco S&P SmallCap Health Care ETF · Innovator IBD 50 ETF
Details →About TG Therapeutics
- What technical signals does TG Therapeutics (TGTX) have?
- TG Therapeutics current technical signals: death cross (5_20, 0d ago).
- Is TG Therapeutics a cup-and-handle pattern?
- No. TG Therapeutics has no valid Cup signal right now.
- What published figures are available for TG Therapeutics?
- Market cap: $8.62B. Trailing 12 months PER: 19.3×. Latest quarter PBR: 14.14×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about TG Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).